Top Markets
Coin of the day
Kindstar Globalgene Technology, Inc. Kindstar Globalgene Technology, Inc.

Kindstar Globalgene Technology, Inc.

9960
株式のランク #20779
Kindstar Global (Beijing) Technology, Inc. is a prominent provider of highly... Kindstar Global (Beijing) Technology, Inc. is a prominent provider of highly specialized diagnostic services to healthcare institutions across China. Beyond just diagnostics, the company extends its expertise to support medical research, clinical drug trials, and translational medicine initiatives for a diverse client base, including individual practitioners, research organizations, various hospital types, and pharmaceutical firms. This broad service portfolio is underpinned by its extensive, state-of-the-art laboratory infrastructure, which encompasses disciplines such as flow cytometry, cytogenetics, medical genomics, molecular biology, hematopathology, mass spectrometry, pathology, clinical immunology, and microbiology, alongside dedicated scientific research labs. Kindstar Global offers a comprehensive range of diagnostic tests covering key areas like hematology (blood), oncology (tumor), and genetic disorders. Its capabilities also extend to diseases affecting the cardiovascular and cerebrovascular systems, infectious agents, and autoimmune conditions, supporting various medical specialties including internal medicine, surgery, gynecology, pediatrics, and numerous other clinical fields. Established in 2003, the company maintains its headquarters in Wuhan, China.
株価
$0.11769213
時価総額
$121.61M
変化(1日)
-0.54%
変化(1年)
-45.26%
CN
取引 Kindstar Globalgene Technology, Inc. (9960)

カテゴリー

Kindstar Globalgene Technology, Inc.(9960)の収益
Aug 2026 時点の収益 TTM: 0
Kindstar Globalgene Technology, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Kindstar Globalgene Technology, Inc. の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益